Cliff Notes
- UK Health Secretary Wes Streeting has raised concerns that Donald Trump‘s tariffs may soon affect the supply of medicines in the UK, amidst ongoing issues in international medicine production and distribution.
- The UK government is actively monitoring the situation, having already witnessed a series of tariffs imposed by the US, including a 10% tax on imports and a 25% levy on cars.
- The recent tariffs could have significant repercussions for UK industries, particularly the automotive sector, with the US being a crucial market for British car exports.
Trump tariffs could disrupt medicine supplies to UK, warns health secretary
Donald Trump’s tariffs could disrupt the supply of medicines into the UK, the health secretary has warned.
Wes Streeting said the government was “constantly watching and acting on this situation” after the US president refused to back down from the punitive policy, despite turmoil in the markets.
So far Mr Trump has imposed a series of tariffs of varying severity on countries across the world, including a 10% baseline tax on imports from all nations and a 25% levy on all cars imported to the US.
His actions have sparked fears of a global trade war, with the UK’s benchmark stock market index, the FTSE 100, only just witnessing a slight rise this morning after three days of steep losses.
While the reciprocal tariffs have not yet included pharmaceutical products, there are concerns this could change in the near future.
Speaking to Wilfred Frost on Sky News Breakfast, the health secretary said that even before the US president’s tariff agenda – which has seen him impose a 10% baseline tax on imports from all nations – there had been “issues with medicines production and supply internationally”.
“We are constantly watching and acting on this situation to try and get medicines into the country, to make sure we’ve got availability, to show some flexibility in terms of how medicines are dispensed, to deal with shortages,” he said.
“But whether it’s medicines, whether it’s parts for manufacturing, whether it’s… the ability of businesses in this country to turn a profit, this is an extremely turbulent situation.”
Mr Streeting, who was speaking following the announcement that the government has recruited more than 1,500 new GPs since 1 October, said the steps taken by Mr Trump were “unprecedented in terms of global trade”.
“As ever in terms of medicines, there’s a number of factors at play,” he said.
“There have been challenges in terms of manufacturing, challenges in terms of distribution, and if we start to see tariffs kicking in, that’s another layer of challenge, but we watch this situation extremely closely.
“We work on a daily basis to make sure that we have the medicine supply this country needs.”